Oakwood Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Oakwood Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$5M	Sell	74,893 -220	-0.3%	-$14.3K	1.29%	36
2021 Q1	$4.74M	Buy	75,113 +1,940	+3%	+$121K	1.4%	33
2020 Q4	$4.54M	Sell	73,173 -992	-1%	-$61K	1.38%	35
2020 Q3	$4.47M	Sell	74,165 -485	-0.6%	-$29.2K	1.65%	29
2020 Q2	$4.39M	Buy	74,650 +4,361	+6%	+$261K	1.83%	25
2020 Q1	$3.92M	Buy	70,289 +135	+0.2%	+$8.25K	2.07%	24
2019 Q4	$4.5M	Buy	+70,154	New	+$4.02M	1.87%	28
2016 Q3	–	Sell	-2,854	Closed	-$210K	–	73
2016 Q2	$210K	Buy	+2,854	New	+$202K	0.05%	70
2016 Q1	–	Sell	-3,144	Closed	-$216K	–	74
2015 Q4	$216K	Buy	+3,144	New	+$208K	0.06%	75
2015 Q3	–	Sell	-3,280	Closed	-$218K	–	86
2015 Q2	$218K	Buy	+3,280	New	+$216K	0.06%	78
2015 Q1	–	Sell	-3,702	Closed	-$219K	–	90
2014 Q4	$219K	Sell	3,702 -264	-7%	-$14.9K	0.06%	79
2014 Q3	$203K	Buy	+3,966	New	+$198K	0.06%	82

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Oakwood Capital Management's BMY Position: Q2 2021 in Review

Oakwood Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 0.29% in Q2 2021, selling an estimated $14.3K and leaving 74,893 shares worth $5M. The position accounts for 1.29% of the portfolio, ranked #36.

Oakwood Capital Management first reported a position in BMY in Q3 2014 and has held it in 12 quarters since. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Oakwood Capital Management held 74,893 shares of Bristol-Myers Squibb worth $5M as of Q2 2021.
Oakwood Capital Management sold 220 Bristol-Myers Squibb shares in Q2 2021, an estimated $14.3K.
Bristol-Myers Squibb made up 1.29% of Oakwood Capital Management's portfolio in Q2 2021, its #36 holding.
Oakwood Capital Management first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 12 quarters since.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Oakwood Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.